{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:49Z","timestamp":1788322669513,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["APP1048222"],"award-info":[{"award-number":["APP1048222"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NHMRC Fellowship","award":["APP1125000"],"award-info":[{"award-number":["APP1125000"]}]},{"name":"NHMRC Senior Principal Research Fellowship","award":["1059660"],"award-info":[{"award-number":["1059660"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.euroneuro.2018.07.098","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T02:49:21Z","timestamp":1534214961000},"page":"1126-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9287-8854","authenticated-orcid":false,"given":"Jerome","family":"Sarris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Con","family":"Stough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-9349","authenticated-orcid":false,"given":"Laura","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"Cribb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1495-8282","authenticated-orcid":false,"given":"Suneel","family":"Chamoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mischoulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.07.098_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders,","year":"2013"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.npp.1301462","article-title":"Association of the COMT val158met variant with antidepressant treatment response in major depression","volume":"33","author":"Baune","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0003","series-title":"BDI-II Beck Depressions-Inventar Revision Manual","author":"Beck","year":"2006"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0004","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists\u2019 Collaboration","volume":"316","author":"Clarke","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HRP.0b013e3182a75cc7","article-title":"Massachusetts general hospital SAFER criteria for clinical trials and research","volume":"21","author":"Desseilles","year":"2013","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0006","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eurpsy.2011.01.003","article-title":"SAMe and sexual functioning","volume":"27","author":"Dording","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0007","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4088\/JCP.10r05976blu","article-title":"Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants","volume":"71","author":"Freeman","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0008","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0009","series-title":"CGI: Clinical Global Impressions","year":"1970"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0010","first-page":"81","article-title":"Hamilton anxiety rating scale (HAM-A)","volume":"61","author":"Hamilton","year":"1959","journal-title":"J. Med."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0011","first-page":"91","article-title":"What are the implications of the STAR*D trial for primary care? A review and synthesis","volume":"10","author":"Huynh","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0012","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","article-title":"Pharmacological approaches to the challenge of treatment-resistant depression","volume":"17","author":"Ionescu","year":"2015","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0013","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3233\/JAD-170177","article-title":"S-Adenosylmethionine attenuates oxidative stress and neuroinflammation induced by amyloid-\u03b2 through modulation of glutathione metabolism","volume":"58","author":"Li","year":"2017","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12264-016-0023-z","article-title":"S-adenosylmethionine administration attenuates low brain-derived neurotrophic factor expression induced by chronic cerebrovascular hypoperfusion or beta amyloid treatment","volume":"32","author":"Li","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0016","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.mp.4001615","article-title":"Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study","volume":"10","author":"Massat","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona sexual experience scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J. Sex Marital Ther."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0018","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4176825","article-title":"A review of the conceptualisation and risk factors associated with treatment-resistant depression","author":"Murphy","year":"2017","journal-title":"Depress. Res. Treat."},{"issue":"Suppl 5","key":"10.1016\/j.euroneuro.2018.07.098_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4088\/JCP.8157su1c.04","article-title":"Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder","volume":"70","author":"Papakostas","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0021","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2016.09.029","article-title":"The properties and utility of the CORE measure of melancholia","author":"Parker","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0023","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.pnpbp.2005.06.027","article-title":"Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses","volume":"29","author":"Reif","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-244X-7-65","article-title":"Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial","volume":"7","author":"Roberts","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0035-1549928","article-title":"Is S-adenosyl methionine (SAMe) for depression only effective in males? A Re-analysis of data from a randomized clinical trial","volume":"48","author":"Sarris","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.aimed.2015.02.001","article-title":"An adjunctive antidepressant nutraceutical combination in treating major depression: study protocol, and clinical considerations","volume":"2","author":"Sarris","year":"2015","journal-title":"Adv. Integr. Med."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0027","series-title":"STOP, THAT and One Hundred Other Sleep Scales, STOP, THAT and One Hundred Other Sleep Scales","author":"Shahid","year":"2012"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0028","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0269881104042630","article-title":"Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Taylor","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0029","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med. Care"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0030","first-page":"132","article-title":"S-adenosylmethionine (SAMe) as treatment for depression: a systematic review","volume":"28","author":"Williams","year":"2005","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2013.06.015","article-title":"Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies","author":"Wu","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.euroneuro.2018.07.098_bib0032","first-page":"1","article-title":"S-adenosylmethionine promotes oxidative stress and decreases Na+, K+-ATPase activity in cerebral cortex supernatants of adolescent rats: implications for the pathogenesis of S-adenosylhomocysteine hydrolase deficiency","author":"Zanatta","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18302815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18302815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:52:37Z","timestamp":1760377957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18302815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0924977X18302815"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.07.098","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.07.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}